🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicholas T. Terrigino

National Cancer Institute

ORCID: 0000-0002-0829-8433
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response”.

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2344
N/A
1.2DataRank · unranked
38 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition

Journal of Clinical Investigation(2025)10.1172/jci189900
N/A
0.172DataRank · unranked
2 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +26 more

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

medRxiv(2020)10.1101/2020.09.29.20199711
N/A
0DataRank · unranked
12 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.368
N/A
0DataRank · unranked
0 citations

Ravi A. Madan, Adam G. Sowalsky, Marijo Bilušić, Guinevere Chun, Lisa M. Cordes +9 more

Multiple primary prostate tumors with differential drug sensitivity.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.342
N/A
0DataRank · unranked
0 citations

Huihui Ye, Nicholas T. Terrigino, Nicole V. Carrabba, Rayann Atway, Shana Y. Trostel +14 more

A case report of multiple primary prostate tumors with differential drug sensitivity

Nature Communications(2020)10.1038/s41467-020-14657-7
N/A
0DataRank · unranked
40 citations

Stephanie A. Harmon, Nicholas T. Terrigino, Fatima Karzai, Peter A. Pinto, Ravi A. Madan +16 more

Prostate-specific membrane antigen is a biomarker for residual disease following neoadjuvant intense androgen deprivation therapy in prostate cancer

medRxiv(2021)10.1101/2021.10.28.21265614
N/A
0DataRank · unranked
0 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Shana Y. Trostel, Nicole V. Carrabba +5 more

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

The Journal of Urology(2022)10.1097/ju.0000000000002492
N/A
0DataRank · unranked
5 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Nichelle C. Whitlock, Shana Y. Trostel +6 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054
N/A
0DataRank · unranked
0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054.v1
N/A
0DataRank · unranked
0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

medRxiv(2024)10.1101/2024.02.09.24302395
N/A
0DataRank · unranked
4 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +21 more

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

European Urology(2021)10.1016/j.eururo.2021.03.009
N/A
0DataRank · unranked
74 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity

Oncogene(2020)10.1038/s41388-020-01389-7
N/A
0DataRank · unranked
34 citations

Shana Y. Trostel, Scott Wilkinson, Nicholas T. Terrigino, S. Thomas Hennigan, Ross Lake +8 more